Intas Gets CDSCO Panel Nod to Conduct Phase III Trial of Pertuzumab Biosimilar for Breast Cancer Dr. Divya Colin11 Jun 2025 5:45 PM ISTNew Delhi: Intas Pharmaceuticals has received approval from the Subject Expert Committee (SEC), functioning under the Central Drugs Standard...
Lupin's TB Drug Isoniazid Dispersible Tablets Cleared for Launch by CDSCO Panel Dr. Divya Colin10 Jun 2025 5:30 PM ISTNew Delhi: In response to a proposal submitted by Lupin Limited, the Subject Expert Committee (SEC) operating under the Central Drugs Standard Control...
AstraZeneca Pharma India names Praveen Rao Akkinepally as new MD, succeeding Dr Sanjeev Panchal Ruchika Sharma9 Jun 2025 6:39 PM ISTBangalore: AstraZeneca Pharma India has announced the appointment of Praveen Rao Akkinepally as the new Managing Director of the company,...
CDSCO Panel Approves Bayer's Real-World Use Study for Heart Failure Drug Vericiguat Dr. Divya Colin8 Jun 2025 12:56 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Bayer...
EMA flags rare vision risk with Semaglutide- a active substance in Ozempic, Rybelsus, Wegovy Ruchika Sharma7 Jun 2025 4:52 PM ISTEuropean Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide following concerns...
NPPA sets retail prices for 41 drugs, including 29 Fixed-Dose Combinations containing Empagliflozin or Sitagliptin Ruchika Sharma5 Jun 2025 4:05 PM ISTNew Delhi: In its 133rd meeting held on May 29, 2025, the National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 41...
Cipla Gets CDSCO Panel Nod To BE Study, Phase III Trial of Semaglutide for Weight Management Dr. Divya Colin4 Jun 2025 2:52 PM ISTNew Delhi: Drug major Cipla has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Crackdown on Pharma Influence: Govt Bans Medical Reps from Central Hospitals Farhat Nasim3 Jun 2025 6:28 PM ISTNew Delhi: The Directorate General of Health Services (DGHS) under the Ministry of Health and Family Welfare has directed all central government...
Dr Reddy's Gets Rs 2,395 Crore Tax Notice Over Merger, Says No Material Impact Farhat Nasim2 Jun 2025 12:27 PM ISTNew Delhi: Drug major, Dr. Reddy's Laboratories Ltd. has disclosed that it has received an order from the Income Tax Department under Section 148A(3)...
ASCI Flags 233 Health Ads for DMR Act Violation, Reports to AYUSH Ministry Farhat Nasim1 Jun 2025 3:00 PM ISTNew Delhi: In a robust effort to regulate misleading health-related advertisements, the Advertising Standards Council of India (ASCI) has flagged 233...
Don't throw in the bin, please flush it! CDSCO dictum for these 17 medicines Farhat Nasim31 May 2025 6:21 PM ISTNew Delhi: In a move to streamline the disposal of expired or unused medicines, the Central Drugs Standard Control Organisation (CDSCO) has issued a...
Dr Reddy's Gets SEC Nod for Higher Semaglutide Dose in Ongoing Phase III Study, Govt Sites Mandated Dr. Divya Colin30 May 2025 8:14 PM ISTNew Delhi: In response to the proposal presented by the Dr Reddy's Laboratories, the Subject Expert Committee (SEC) functional under the Central Drug...
